Literature DB >> 23239541

A 137-kb deletion within the Potocki-Shaffer syndrome interval on chromosome 11p11.2 associated with developmental delay and hypotonia.

Nathan D Montgomery1, Christie M Turcott, James H Tepperberg, Marie T McDonald, Arthur S Aylsworth.   

Abstract

Potocki-Shaffer syndrome (PSS) is a rare disorder caused by haploinsufficiency of genes located on the proximal short arm of chromosome 11 (11p11.2p12). Classic features include biparietal foramina, multiple exostoses, profound hypotonia, dysmorphic features, and developmental delay/intellectual disability. Fewer than 40 individuals with PSS have been reported, with variable clinical presentations due in part to disparity in deletion sizes. We report on a boy who presented for initial evaluation at age 13 months because of a history of developmental delay, hypotonia, subtle dysmorphic features, and neurobehavioral abnormalities. SNP microarray analysis identified a 137 kb deletion at 11p11.2, which maps within the classically defined PSS interval. This deletion results in haploinsufficiency for all or portions of six OMIM genes: SLC35C1, CRY2, MAPK8IP1, PEX16, GYLTL1B, and PHF21A. Recently, translocations interrupting PHF21A have been associated with intellectual disability and craniofacial anomalies similar to those seen in PSS. The identification of this small deletion in a child with developmental delay and hypotonia provides further evidence for the genetic basis of developmental disability and identifies a critical region sufficient to cause hypotonia in this syndrome. Additionally, this case illustrates the utility of high resolution genomic approaches in correlating clinical phenotypes with specific genes in contiguous gene deletion syndromes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239541     DOI: 10.1002/ajmg.a.35671

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

2.  The first Korean patient with Potocki-Shaffer syndrome: a rare cause of multiple exostoses.

Authors:  Young Bae Sohn; Shin-Young Yim; Eun-Hae Cho; Ok-Hwa Kim
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

3.  Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder.

Authors:  Tom S Koemans; Tjitske Kleefstra; Melissa C Chubak; Max H Stone; Margot R F Reijnders; Sonja de Munnik; Marjolein H Willemsen; Michaela Fenckova; Connie T R M Stumpel; Levinus A Bok; Margarita Sifuentes Saenz; Kyna A Byerly; Linda B Baughn; Alexander P A Stegmann; Rolph Pfundt; Huiqing Zhou; Hans van Bokhoven; Annette Schenck; Jamie M Kramer
Journal:  PLoS Genet       Date:  2017-10-25       Impact factor: 5.917

4.  Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.

Authors:  Hyung-Goo Kim; Jill A Rosenfeld; Daryl A Scott; Gerard Bénédicte; Jonathan D Labonne; Jason Brown; Marianne McGuire; Sonal Mahida; Sakkubai Naidu; Jacqueline Gutierrez; Gaetan Lesca; Vincent des Portes; Ange-Line Bruel; Arthur Sorlin; Fan Xia; Yline Capri; Eric Muller; Dianalee McKnight; Erin Torti; Franz Rüschendorf; Oliver Hummel; Zeyaul Islam; Prasanna R Kolatkar; Lawrence C Layman; Duchwan Ryu; Il-Keun Kong; Suneeta Madan-Khetarpal; Cheol-Hee Kim
Journal:  Mol Autism       Date:  2019-10-22       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.